Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3988908 | Journal of the Egyptian National Cancer Institute | 2016 | 4 Pages |
Abstract
Bleomycin induced flagellate dermatitis is an uncommon and unique adverse effect. With the declining use of bleomycin, this complication is becoming increasingly infrequent in day-to-day clinical practice. We herein describe a case of a 13 year old male patient with left thalamic mixed germ cell tumour treated by multimodality approach, who developed flagellate erythema after two cycles of combination chemotherapy with bleomycin, etoposide and cisplatin (BEP). This brief report highlights the importance of awareness and timely identification and management of this dermatological toxicity in patients undergoing bleomycin based combination chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ahitagni Biswas, Pramod Kumar Julka,